Skip to content

MINIMAKI_PATIENTS: Clinical and ethical requirements analysis for patient education during informed consent explanations using HoloLens technology in the context of mitral valve therapy.

MINIMAKI_PATIENTS: Clinical and ethical requirements analysis for patient education during informed consent explanations using HoloLens technology in the context of mitral valve therapy. - MINIMAKI_PATIENTS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032541
Enrollment
8
Registered
2023-08-23
Start date
2024-01-31
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z95

Interventions

Group 1: Patients who have undergone surgery on the mitral valve will be interviewed about their experiences with medical information and their expectations for medical information using augmented rea

Sponsors

Fraunhofer MEVIS und Deutsches Herzzentrum Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: former patients who had a successful mitral valve surgery at the Charité, informed consent given, a good coping with the disease, good German language skills

Exclusion criteria

Exclusion criteria: no informed consent, no sufficient German language skills

Design outcomes

Primary

MeasureTime frame
Ethical and clinical requirements for medical information using augmented reality devices are collected using interview on postoperative patients.

Secondary

MeasureTime frame
Knowledge, communication, medical decision making Data collected by means of interviews with patients who have undergone surgery on mitral valve

Countries

Germany

Contacts

Public ContactSusanne Michl

Charité- Universitätsmedizin Berlin, Institut für Geschichte der Medizin und Ethik in der Medizin

susanne.michl@charite.de004930450529045

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026